This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Agilent Technologies, with offices in Carpinteria, announced a product designed to identify previously untreated non-small cell lung cancer patients with a tumor proportion score of 50 percent or more was approved for use in Europe in conjunction with Merck’s Keytruda therapy. Before using the product – called PD-L1 IHC 22C3 pharmDx and developed by Agilent Read More →
UC Santa Barbara’s Institute for Energy Efficiency will play a lead role in a $110 million federal program to develop new electronic products using the next generation of chip technology. UCSB will become the west coast hub for the newly formed American Institute for Manufacturing of Photonics (AIM), teaming with lead institution State University of Read More →